Association between antibiotic usage during infancy and asthma incidence among children: a population-level

Abdullah Al Mamun1,2, Carl Zou2, Hannah Lishman2

  • 1School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.

Frontiers in Allergy
|September 17, 2024
PubMed

Insights

Reduced antibiotic use and increased breastfeeding in infants are linked to a significant decrease in childhood asthma incidence. These factors explain much of the observed population trend in asthma rates over two decades.

Area of Science:

  • Pediatric Health
  • Epidemiology
  • Public Health

Background:

  • Published associations link antibiotic use to asthma development in children.
  • Trends in British Columbia (BC) from 2000-2019 show reduced antibiotic prescribing and increased breastfeeding.
  • Asthma incidence in BC children has also shown a declining trend during this period.

Purpose of the Study:

  • To model the predicted incidence of asthma in BC children.
  • To assess the impact of reduced antibiotic use and increased breastfeeding on asthma incidence.
  • To evaluate the population attributable risk (PAR) of asthma related to antibiotic exposure.

Main Methods:

  • A population-based ecological study utilized BC PharmaNet antibiotic prescription data and the Chronic Disease Registry for asthma diagnoses.
  • Breastfeeding estimates were derived from the Canadian Community Health Survey (CCHS).
  • Negative binomial regression analyzed the association between infant antibiotic prescribing and childhood asthma incidence, stratified by time periods.

Main Results:

  • Antibiotic prescribing in infants decreased by 77%, and asthma incidence in children aged 1-4 years dropped by 41% from 2000-2019.
  • BC breastfeeding rates rose from 46% (2005) to 71% (2017/18).
  • The predicted asthma incidence in 2019 (18.8/1,000) was comparable to the observed incidence (16.6/1,000), with the association between antibiotic use and asthma weakening over time due to increased breastfeeding.

Conclusions:

  • Significant decreases in infant antibiotic exposure and childhood asthma incidence were observed over 20 years.
  • Reduced antibiotic exposure and increased breastfeeding appear to explain a substantial portion of the population trend in asthma.
  • While these factors are significant, other environmental and social exposures remain relevant to asthma etiology.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
246
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
246
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
371
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K